To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours
Clinical trial NCT01900028 · COMPLETED
Trial details
- NCT number
- NCT01900028
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.